Supracervical hysterectomy in patients with advanced epithelial ovarian cancer

Obstetrics and Gynecology

Volumn 109, Issue 3, 2007, Pages 641-646

  Milam, Michael R ^b   Sood, Anil K ^b   King, Sara ^b   Bassett Jr , Roland L ^b   Lu, Karen H ^b   Slomovitz, Brian M ^b   Coleman, Robert L ^b   Ramirez, Pedro T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; PACLITAXEL;

ABDOMINAL HYSTERECTOMY; ADULT; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HUMAN; HYSTERECTOMY; LOG RANK TEST; MEDICAL RECORD REVIEW; OVARY CANCER; PEROPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SAMPLE SIZE; STUDENT T TEST; SURVIVAL RATE; SURVIVAL TIME;

FEMALE; HUMANS; HYSTERECTOMY; INTRAOPERATIVE COMPLICATIONS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33847387040     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000257117.78230.0f     Document Type: Review

References (12)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-30.
2. Disaia PJ, Creasman WT. Clinical gynecologic oncology. 6th ed. St. Louis (MO): Mosby; 2002.
3. Esdaile BA, Chalian RA, Del Priore G, Smith JR. The role of supracervical hysterectomy in benign disease of the uterus. J Obstet Gynaecol 2006;26:52-8.
4. Kuppermann M, Summitt RL Jr, Varner RE, McNeeley SG, Goodman-Gruen D, Learman LA, et al. Sexual functioning after total compared with supracervical hysterectomy: a randomized trial. Obstet Gynecol 2005;105:1309-18.
5. Jones DE, Shackelford DP, Brame RG. Supracervical hysterectomy: back to the future? Am J Obstet Gynecol 1999;180:513-5.
6. Markman M, Walker JL. Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment. J Clin Oncol 2006;24:988-94.
7. Walker JL, Armstrong DK, Huang HQ, Fowler J, Webster K, Burger RA, et al. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group Study. Gynecol Oncol 2006;100:27-32.
8. Lupi G, Fontanelli R, Jin R, Grosso G. Second surgical treatment of retroperitoneal persistent disease in epithelial ovarian cancer. Tumori 1996;82:81-4.
9. Bhoola S, Hoskins WJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol 2006;107:1399-410.
10. Munkarah AR, Hallum AV 3rd, Morris M, Burke TW, Levenback C, Atkinson EN, et al. Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer. Gynecol Oncol 1997;64:13-7.
11. Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006;354:34-43.
12. Learman LA, Summitt RL Jr, Varner RE, McNeeley SG, Goodman-Gruen D, Richter HE, et al. A randomized comparison of total or supracervical hysterectomy: surgical complications and clinical outcomes. Obstet Gynecol 2003;102:453-62.